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Abstract
Background: Serious mental illness (SMI), which encompasses a set of chronic conditions such as schizophrenia,
bipolar disorder and other psychoses, accounts for 3.4 m (7 %) total bed days in the English NHS. The introduction
of prospective payment to reimburse hospitals makes an understanding of the key drivers of length of stay (LOS)
imperative. Existing evidence, based on mainly small scale and cross-sectional studies, is mixed. Our study is the first
to use large-scale national routine data to track English hospitals’ LOS for patients with a main diagnosis of SMI
over time to examine the patient and local area factors influencing LOS and quantify the provider level effects to
draw out the implications for payment systems.
Methods: We analysed variation in LOS for all SMI admissions to English hospitals from 2006 to 2010 using
Hospital Episodes Statistics (HES). We considered patients with a LOS of up to 180 days and estimated Poisson
regression models with hospital fixed effects, separately for admissions with one of three main diagnoses:
schizophrenia; psychotic and schizoaffective disorder; and bipolar affective disorder. We analysed the independent
contribution of potential determinants of LOS including clinical and socioeconomic characteristics of the patient,
access to and quality of primary care, and local area characteristics. We examined the degree of unexplained variation
in provider LOS.
Results: Most risk factors did not have a differential effect on LOS for different diagnostic sub-groups, however we did
find some heterogeneity in the effects. Shorter LOS in the pooled model was associated with co-morbid substance or
alcohol misuse (4 days), and personality disorder (8 days). Longer LOS was associated with older age (up to 19 days),
black ethnicity (4 days), and formal detention (16 days). Gender was not a significant predictor. Patients who
self-discharged had shorter LOS (20 days). No association was found between higher primary care quality and
LOS. We found large differences between providers in unexplained variation in LOS.
Conclusions: By identifying key determinants of LOS our results contribute to a better understanding of the
implications of case-mix to ensure prospective payment systems reflect accurately the resource use within
sub-groups of patients with SMI.
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Background
Serious mental illness (SMI) encompasses a range of
chronic and frequently disabling conditions including
schizophrenia, bipolar disorder and psychoses. These
conditions are associated with substantial morbidity and
mortality. The life expectancy of SMI patients is 10 to
15 years shorter than the general population in England
[1], and 15 to 20 years shorter in Denmark, Finland and
Sweden [2]. A recent global morbidity study attributed
3.5 % of total Years Lost to Disability to schizophrenia
and bipolar disorder combined [3]. The two diseases
alone are estimated to constitute 1.5 % of the total Dis-
ability Adjusted Life Year burden of disease for the UK
in 2010 [4] and 1.1 % in 21 regions worldwide [5].
People with SMI are at higher risk of hospitalisations
than the general population [6, 7] as physical comorbid-
ity is more common [8, 9]. SMI is associated with in-
creased treatment costs [10] and hospitalisation for this
patient group represents a significant proportion of
health care resource use. In England, these illnesses ac-
count for 3.4 million or 7.2 % of total bed days [11]. This
paper examines the key patient and local area determi-
nants of inpatient length of stay (LOS) for patients with
a main diagnosis of SMI and examines the variation in
LOS between hospital providers in England.
The delivery of mental health services and the incen-
tives that service providers face have changed radically
in the last few decades. Most western health care sys-
tems have deinstitutionalised care for patients with
mental health problems and shifted treatment from sec-
ondary care settings into the community [12]. This has
led to significant reductions in average LOS and also in
overall numbers of psychiatric beds. More recently,
policy shifts have focused on changes in funding ar-
rangements for mental health care as a response to
pressure to contain costs. Whereas most health care
systems reimburse the full costs for providers of in-
patient care, several are considering the use of activity-
based prospective payment systems, similar to those
already in use in the acute physical care setting, in
order to reduce costs [13]. Canada (Ontario), Australia
and New Zealand have developed case-mix classifica-
tion systems for mental health services which have in-
cluded information on diagnosis. In Australia and New
Zealand provider factors were shown to significantly
drive cost variations making the classification systems
unsuitable for provider payment [13].
In England, the National Health Service (NHS) is mov-
ing away from traditional block contracts towards a more
transparent prospective funding for providers called the
National Tariff Payment System (NTPS) (formerly known
as Payment by Results (PbR) [14]). Under the NTPS,
patients are classified into one of 21 care clusters based
on need and severity, rather than diagnostic coding. These
clusters are in turn grouped into three super-classes corre-
sponding to non-psychotic, psychosis and organic mental
illness. The intention is that each cluster will have a fixed
national price based on the national weighted average cost
of admitted and non-admitted care. Each cluster has a
specific review period attached to it with payments made
to cover all care during the cluster review period. Whilst
the current implementation of NTPS focuses on the de-
velopment of locally negotiated cluster prices, the move
towards a national fixed price payment system would
provide a strong incentive to control costs and should
therefore encourage providers to reduce LOS. Evidence
from the US has reported reductions in LOS following the
introduction of a prospective payment system in psychi-
atric care, as well as reductions in LOS due to anticipatory
effects prior to payments starting [15, 16]. LOS for in-
patient care is a major driver of resource use and is highly
correlated with hospital costs, especially when care is
labour-intensive as is the case in mental health [17]. Re-
ductions in LOS may reduce the very high psychiatric bed
occupancy rates observed in the English NHS and the as-
sociated difficulties in accessing acute psychiatric beds for
severely ill patients in crisis [18], although driving down
reductions in LOS too far can impact on quality and out-
comes and may increase readmission rates [19–21].
Differences in LOS across providers can reflect differ-
ences in patient needs, but can also be indicative of
differences in treatment philosophies and practice patterns
[22] and in efficiency of care provision. A better under-
standing of the factors which determine LOS is imperative
for the design of payment systems, e.g. by identifying high
cost casemix profiles. Estimates of how LOS varies be-
tween providers after allowing for differences in case-mix
can also provide measures of the extent to which LOS
may be amenable to potential reductions by high cost pro-
viders in response to the introduction of a prospective
payment system. Given the high proportion of bed days
and the high cost associated with the care of people with
psychotic disorders, as well as the fact that psychosis is
one of the three super-classes in the NTPS, this study fo-
cuses on the determinants of LOS for people with SMI.
There is conflicting evidence about the key determi-
nants of hospital LOS for people with SMI. This may in
part reflect the methodological weaknesses in many previ-
ous studies. Many studies are cross-sectional with small
samples split into case–control groups by mean or median
LOS in order to examine the difference between long and
short-stays, typically using logistic regression. Comparing
sub-populations in this way leads to inconsistent findings
as LOS is typically skewed and sub-populations may be
small [12]. Single site studies are not generalisable to other
settings with a different patient case-mix [23]. Finally, SMI
covers a range of clinical sub-groups with different treat-
ment requirements. Studies to date have typically pooled
Jacobs et al. BMC Health Services Research  (2015) 15:439 Page 2 of 16
clinical sub-groups to increase their sample size, making
the untested assumption that risk factors will have the
same effect on all sub-groups.
This study has two aims. First, we aim to assess the in-
dependent effects of patient characteristics (case-mix)
and local area characteristics on LOS and study whether
there is heterogeneity in those effects across patient sub-
groups with SMI. We improve on previous work by
using large scale administrative datasets to investigate
factors associated with LOS. Second, we aim to assess
the degree of unexplained variation in provider LOS i.e.
the variation which remains after controlling for the pa-
tient and local area characteristics in our model. The re-
sidual unexplained variation in LOS may be interpreted
as the element most amenable to influence by policy-
makers and providers. Thus it may help to define the
limits on the extent to which a prospective payment sys-
tem for providers may be successful in reducing LOS
and costs.
Determinants of length of stay for patients with serious
mental illness
We searched the literature for key determinants of LOS
for patients with SMI to identify a relevant set of explana-
tory variables for subsequent analysis. We searched several
bibliographic databases (e.g. PubMed, EMBASE, Psy-
cINFO) to identify relevant literature published between
1946 and 2014. Our search strategy (see Additional file 1:
Appendix 1) included terms for schizophrenia, psychotic
disorders, bipolar disorder; for trials, cohort studies or sys-
tematic reviews; and length of stay. Titles were screened
and abstracts were checked for relevance from 132 arti-
cles. We found 15 studies with LOS as the primary or sec-
ondary outcome for patients with SMI specifically. We
also identified 5 studies from alternative sources such as
suggestions from experts.
Most studies consider 3 groups of predictor variables:
(a) socio-demographic characteristics of patients (e.g. age,
gender, living arrangements, degree of social support, eth-
nicity, insurance status); (b) clinical characteristics (e.g.
psychiatric diagnosis, severity, legal status/compulsory ad-
mission, psychiatric or physical co-morbidities, measure
of functioning, previous admissions, medication); and (c)
characteristics of hospitals or the health care system (e.g.
type of hospital, measures of quality of care).
While some studies covered a wide array of determi-
nants, many of these were found not to be significant
and the results for some factors differed across studies.
Socio-demographic characteristics which were associ-
ated with increased LOS for patients with SMI include
being single / not married [24–26], having accommoda-
tion or housing problems [12, 26–28], having no educa-
tional qualification [12, 29], being on a national health
insurance plan [30, 31], and being in receipt of welfare
[29], whilst higher deprivation was associated with
shorter LOS in another study [32]. There is limited evi-
dence of an effect for ethnicity [25]. Being a foreigner
was associated with increased LOS in one study [29]
while being a migrant was associated with reduced LOS
in another [12]. Having family ties or social support
was also associated with reduced LOS [33, 34]. Older age
was associated with increased LOS in some studies [25,
30, 32, 33, 35], and reduced LOS in others [29, 31, 36],
while male gender was associated with increased LOS
in some studies [24, 30, 31], and reduced LOS in others
[25, 26, 32, 37].
Clinical characteristics which were associated with
increased LOS for patients with SMI include: a pri-
mary diagnosis of schizophrenia or psychosis [25–27,
29, 31, 32, 35, 36, 38, 39] or a mood disorder [35] al-
though some studies found diagnosis to be a poor pre-
dictor of LOS [39, 40]. Other characteristics associated
with increased LOS were higher severity as measured by
e.g. the Brief Psychiatric Rating Scale (BPRS) [24, 41, 42]
or the Global Assessment of Functioning (GAF) [37] or
other severity indicators [28, 39]. Co-morbidities were as-
sociated with increased LOS in some studies [24, 29],
while having no secondary diagnoses increased LOS in
other studies [30]. A diagnosis of co-morbid substance
abuse was associated with a reduced LOS [35, 37, 39] as
was personality disorder [37]. Prior hospitalisation was as-
sociated with increased LOS in some studies [32, 35, 38]
but with lower LOS in other studies [29]. Previous vio-
lence / forensic history was positively associated with LOS
[28, 33] as was use of seclusion or restraint [12, 37]. Legal
status/compulsory admission as a risk factor was positively
associated with LOS in some studies [23, 38], but nega-
tively in others [25, 26]. Being on an open rather than a
locked ward was associated with reduced LOS [29] as was
having an emergency admission or weekend admission
[32] and being discharged against medical advice [26]. Re-
ceiving psychopharmacological medication, such as neu-
roleptics, antidepressants and lithium was associated with
reduced LOS in one study [29] and increased LOS in
another [27]. Being admitted from another institution was
positively associated with LOS in one study [34] and nega-
tively in another [12].
Finally, characteristics of hospitals and the healthcare
system which were positively associated with LOS include
the patient being treated at a psychiatric hospital, rather
than another type of hospital [30, 31], a higher number of
beds [25, 30, 31], a higher proportion of male patients
[31], and a higher proportion of elderly patients [31]. The
number of health care professionals employed was associ-
ated with reduced LOS [30, 31] as was a shorter distance
from patient’s place of residence to hospital [24]. There
was also evidence of marked regional variation in LOS
[12, 38].
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Methods
Study population
Our study population was all patients aged 18 or over
and admitted with a primary diagnosis of SMI to a
mental health hospital in England during the study
period April 2006 to October 2010. All patients were
followed until March 2011. SMI patients were identified
using ICD-10 diagnostic codes in the primary diagnosis
field of their admission record. Many studies focus on a
wide range of mental health conditions and thus tend
to group the primary diagnoses according to type of
disorder by ICD-10 code (e.g. F2, F3) which also re-
flects severity to some degree [12, 43]. We focussed on
individual conditions within SMI to more accurately as-
sess the impact on resource use for each condition. In
addition to considering the effects of patient and local
area characteristics on LOS for all SMI patients in a
pooled model (1), we also examined patients with three
types of SMI: (2) schizophrenia (F20); (3) schizoaffec-
tive disorders, and schizotypal and delusional disorders
(F21- F29); and (4) bipolar and mood affective disorders
(F30-F31) (see Table 1).
Data sources
Our study combined several datasets. Record-level data
on hospital admissions were obtained from the Hospital
Episodes Statistics (HES) which covers all NHS-funded
secondary care in England. These data are reported as
Finished Consultant Episodes (FCEs) and we converted
these to continuous inpatient spells (CIPS) (admissions).
Using CIPS has the advantage that it reduces coding
errors e.g. where patients leave hospital for a weekend
but are not discharged, they may otherwise be coded as
a new admission on their return. We used HES to derive
our dependent variable (LOS) and a range of demo-
graphic and clinical characteristics. Individual patient re-
cords were linked over time through a unique patient
identifier, based on the patient’s NHS number. Data on
local area-level characteristics (i.e. the number of people
resident in an NHS community psychiatric establish-
ment, and urban status) were sourced from the Office of
National Statistics (ONS). These data were derived from
the 2001 Census and were available at small area level
(Lower Super Output Area (LSOA)). Data on the num-
ber of incapacity benefit claimants at small area level
were obtained from the Department of Work and Pen-
sions. Data on access to and quality of care for patients
with SMI received in primary care were extracted from
the Quality and Outcomes Framework (QOF) dataset
and the GP Patient Survey (GPPS) dataset and linked
to HES through the practice identifier and the year.
Additional file 1: Appendix 2 provides a full list of data-
sets and sources. As confirmed by the University of
York Research Ethics Committee, no ethical approval
was required for this study since it is classed as low risk
due to minimal burden or intrusion for participants as it
is based on the analysis of anonymised secondary data.
Data
LOS for each admission was calculated as the difference
between the dates of admission to and discharge from
hospital. All patients were admitted and discharged
from the same hospital. Patients with unfinished epi-
sodes were dropped from the sample.
For each admission, we also extracted information
from HES on socio-demographic variables such as age
(we categorised patients’ age into seven 10-year bands
and used the first band (18–24) as a reference category),
gender, ethnicity, and carer support; clinical variables in-
cluding main and secondary diagnoses, previous history of
psychiatric care, legal status - whether the patient was
detained under the Mental Health Act; and the mode of
discharge (discharged by clinician, self-discharged, or died
in hospital).
In relation to co-morbidity, previous studies adopt a
range of different approaches, with many studies includ-
ing co-morbidity in terms of secondary diagnoses of a
mental health condition, rather than other clinical con-
ditions. Some ignore this aspect completely [31]; others
record whether a secondary diagnosis was present or ab-
sent [29]; and many tend to focus only on a secondary
diagnosis related to substance or alcohol misuse or per-
sonality disorder [23, 35, 37].
We counted the total number of co-morbidities for a
patient up to a maximum of 13, including secondary
diagnoses for mental health and non-mental health con-
ditions. We imposed a limit of 13 to account for the
change in the number of available fields in HES for re-
cording secondary diagnoses (ranging from 13 in 2006
to 19 in year 2010). We also derived a set of indicator
variables for a secondary diagnosis of co-morbid alcohol
and substance misuse (F10-F19) [35, 37] and co-morbid
personality disorder (F60) [37].
We derived a number of neighbourhood level character-
istics to account for the local context, e.g. the deprivation
profile. We extracted data on the proportion of the local
population who resided in NHS community psychiatric
establishments. Ideally, we would have used a measure
based on the number of beds available each year (rather
than occupancy at one time point). However, as long as
demand for community beds is at least equal to supply,
the measure was considered a reasonable approximation
of capacity and therefore a likely proxy for local area need.
Socio-economic status was approximated by the percent-
age of the local population claiming incapacity benefit for
a mental disorder. Since the LSOA population (i.e. de-
nominator) changed over time, we estimated moving aver-
ages for both these variables. We then categorised the
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Table 1 Descriptive statistics for admissions contributing to the regression analyses
Variable Pooled
(N = 89,510) (1)
Schizophrenia
(N = 38,216) (2)
Psychotic and
schizoaffective disorder
(N = 21,415) (3)
Manic and bipolar
disorder
(N = 29,879) (4)
Main diagnosis (n, %)
Schizophrenia (F20) 38,216 (42.7) 38,216 (100.0)
Schizotypal disorder (F21) 229 (0.3) 229 (1.1)
Persistent delusional disorder (F22) 3,605 (4.0) 3,605 (16.8)
Acute and transient psychotic
disorder (F23)
6,446 (7.2) 6,446 (30.1)
Induced delusional disorder (F24) 66 (0.1) 66 (0.3)
Schizoaffective disorders (F25) 8,200 (9.2) 8,200 (38.3)
Other nonorganic psychotic disorders (F28) 268 (0.3) 268 (1.3)
Unspecified nonorganic psychosis (F29) 2,601 (2.9) 2,601 (12.1)
Manic episode (F30) 2,777 (3.1) 2,777 (9.3)
Bipolar affective disorder (F31) 27,102 (30.3) 27,102 (90.7)
Age (n, %)
Age up to 25 8,224 (9.2) 3,893 (10.2) 2,795 (13.1) 1,536 (5.1)
Age 25-34 17,951 (20.1) 9,213 (24.1) 4,623 (21.6) 4,115 (13.8)
Age 35-44 22,116 (24.7) 10,308 (27.0) 5,094 (23.8) 6,714 (22.5)
Age 45-54 17,997 (20.1) 7,298 (19.1) 3,824 (17.9) 6,875 (23.0)
Age 55-64 11,652 (13.0) 4,194 (11.0) 2,281 (10.7) 5,177 (17.3)
Age 65-74 7,110 (7.9) 2,203 (5.8) 1,402 (6.5) 3,505 (11.7)
Age 75 and over 4,460 (5.0) 1,107 (2.9) 1,396 (6.5) 1,957 (6.5)
Gender (n, %)
Female 42,589 (47.6) 13,217 (34.6) 11,292 (52.7) 18,080 (60.5)
Male 46,921 (52.4) 24,999 (65.4) 10,123 (47.3) 11,799 (39.5)
Detention status (n, %)
Not detained 72,273 (80.7) 30,554 (80.0) 17,039 (79.6) 24,680 (82.6)
Detained 17,237 (19.3) 7,662 (20.0) 4,376 (20.4) 5,199 (17.4)
Ethnicity (n, %)
White 67,980 (75.9) 27,330 (71.5) 15,841 (74.0) 24,809 (83.0)
Mixed 1,822 (2.0) 948 (2.5) 443 (2.1) 431 (1.4)
Asian 6,728 (7.5) 3,290 (8.6) 1,684 (7.9) 1,754 (5.9)
Black 8,898 (9.9) 5,051 (13.2) 2,172 (10.1) 1,675 (5.6)
Unknown or missing 4,082 (4.6) 1,597 (4.2) 1,275 (6.0) 1,210 (4.0)
Patient has a carer (n, %)
No 83,426 (93.2) 35,647 (93.3) 19,958 (93.2) 27,821 (93.1)
Yes 6,084 (6.8) 2,569 (6.7) 1,457 (6.8) 2,058 (6.9)
Patient was previously treated for mental
health issues (n, %)
No 48,126 (53.8) 19,377 (50.7) 12,803 (59.8) 15,946 (53.4)
Yes 41,384 (46.2) 18,839 (49.3) 8,612 (40.2) 13,933 (46.6)
Alcohol and substance misuse (n, %)
No 84,786 (94.7) 35,797 (93.7) 20,304 (94.8) 28,685 (96.0)
Yes 4,724 (5.3) 2,419 (6.3) 1,111 (5.2) 1,194 (4.0)
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deprivation measure (i.e. incapacity claimants) into quin-
tiles. Finally, we accounted for whether the local area was
‘urban’ (defined as having a population above 10,000),
using a dummy variable based on the ‘Rural and Urban
Area Classification for Super Output Areas, 2004’ (from
ONS). This variable was assumed to be time-invariant.
Effective primary care may shorten patients’ LOS in
two ways: firstly, if hospitals can be confident that the
patient will be followed up by the GP practice they may
decide to discharge the patient more quickly. Secondly,
patients with better access to primary care prior to ad-
mission may require a shorter stay once admitted.
The Quality and Outcomes Framework (QOF) is a
pay-for-performance scheme in primary care which
includes a set of indicators for SMI against which prac-
tices score points according to their level of achieve-
ment. We extracted data on the proportion of SMI
patients with a comprehensive care plan documented,
which we interpreted as a measure of quality and con-
tinuity of care. To approximate accessibility of primary
care services, we extracted the proportion of patients re-
ported to have been seen by their GP within 48 h, de-
rived from the annual GP survey. Both variables were
measured at GP practice level and linked to the HES
record through unique practice and year identifiers.
Exclusions
We excluded admissions with very long LOS, defined as
stays over 180 days (approximately 6 months), to reduce
the effect of unusually long stay patients on the stability
of the estimates and focus on a more homogeneous pa-
tient population that reflects the majority of cases seen
in the inpatient setting. These long-stay patients tend to
be different with respect to observable characteristics.
For example, those patients staying longer than 180 days
are twice as likely to be detained and 1.5 times as likely
to have a main diagnosis of schizophrenia (ICD-10: F20).
To ensure our analysis included all patients who could
have stayed in hospital up to the upper threshold, we ex-
cluded admissions that occurred after the 2nd October
2010 calculated as 31st March 2011 minus 180 days.
We also excluded admissions to mental health pro-
viders which treated fewer than 10 admissions for the
particular clinical diagnosis sub-category over our
study period (see study population). Finally, patients
were excluded if they were recorded as living outside
of England.
Analysis
Poisson regression models were estimated to relate ob-
served LOS to patient characteristics, neighbourhood
characteristics and indicators of primary care. All models
included hospital fixed effects to account for unobserved
differences in hospital policies, efficiency, and case-mix.
Hence, coefficients are estimated from within-hospital
variation only. We included time fixed effects to account
for common temporal trends. No exposure term was de-
fined. Poisson regression was appropriate for these data
due to the skewed distribution of LOS. It was also prefera-
ble to logarithmic transformations, which are commonly
Table 1 Descriptive statistics for admissions contributing to the regression analyses (Continued)
Co-morbid personality disorder (n, %)
No 88,329 (98.7) 37,800 (98.9) 21,077 (98.4) 29,452 (98.6)
Yes 1,181 (1.3) 416 (1.1) 338 (1.6) 427 (1.4)
Number of comorbidities (mean, sd) 0.43 (1.0) 0.39 (1.0) 0.47 (1.1) 0.45 (1.1)
Discharge type (n, %)
Discharged by consultant 87,063 (97.3) 37,148 (97.2) 20,790 (97.1) 29,125 (97.5)
Self-discharged 2,017 (2.3) 902 (2.4) 525 (2.5) 590 (2.0)
Died in hospital 430 (0.5) 166 (0.4) 100 (0.5) 164 (0.5)
Resident in urban area (n, %)
No 8,959 (10.0) 2,782 (7.3) 2,251 (10.5) 3,926 (13.1)
Yes 80,551 (90.0) 35,434 (92.7) 19,164 (89.5) 25,953 (86.9)
Percentage mental health benefit claimants
in local community (mean, sd)
2 (1.6) 2.51 (1.7) 2.23 (1.6) 2.03 (1.5)
Percentage population of local community
resident in NHS psychiatric establishment
(mean, sd)
0 (0.3) 0.03 (0.4) 0.02 (0.3) 0.02 (0.3)
GP quality - % practice population with SMI
with care plan (mean, sd)
1 (0.1) 0.84 (0.1) 0.85 (0.1) 0.84 (0.1)
GP access - % practice population able to see
GP within 48 h (mean, sd)
1 (0.1) 0.82 (0.1) 0.82 (0.1) 0.83 (0.1)
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used to analyse LOS, because it estimated the conditional
mean on the scale of interest and did not suffer from re-
transformation bias [44, 45]. Poisson regression is increas-
ingly used to analyse length of stay and cost data, and
has been found to fit those data at least as well as for ex-
ample, Weibull or Cox proportional hazard survival
models [46, 47]. Since censoring was not a major concern
in this study - only 2.7 % of patients self-discharged or
died in hospital - we decided to model these factors as co-
variates. The Poisson estimator produces unbiased point
estimates as long as the conditional mean is correctly spe-
cified. We obtained robust Huber-White standard errors
to account for over-dispersion or other misspecification of
the variance function [48].
Estimated effects are reported as average partial ef-
fects (APEs), which represent the expected change in
LOS for a unit change in the independent variable.
APEs were calculated conditional on hospital fixed ef-
fects, which we recovered after estimation using the
procedure outlined in [48] (p.281). We also calculated
Incidence Rate Ratios (IRRs) with two-sided 95 % confi-
dence intervals, where values greater than 1 indicate an
increase in relative risk of incurring an additional in-
patient day.
All models were estimated on the pooled sample of all
SMI admissions and separately for the three groups of
SMI admissions. We compared the estimated effects
across groups to explore heterogeneity in the effect of
risk factors. We also correlated the hospital fixed effects
estimates across groups to examine whether unobserved
hospital characteristics had a similar effect on LOS for
the different patient groups.
All analyses were conducted in Stata 13.
Results
Descriptive analysis
Our sample included 89,510 admissions for patients
treated in 67 hospitals and who were registered with
7,792 GP practices. Across all five years, the median an-
nual volume of admissions with a primary diagnosis of
SMI was 270.
Approximately 42.7 % of admissions had a recorded
primary diagnosis of schizophrenia, and another 33.4 %
were diagnosed with bipolar disorder or a manic episode
(Table 1). However, there was substantial variation in in-
take across providers. Figure 1 shows the proportion of
patients in each of the three sub-groups by provider. For
some providers, 55 % of the SMI patients were diag-
nosed with schizophrenia, whereas the proportion in
other providers was less than 30 %. Similarly, the pro-
portion of patients with bipolar or mood affective dis-
order was around 40 % (and one as high as nearly 60 %)
in some providers, but was just over 20 % in other
hospitals.
Figure 2 shows a histogram of the distribution of LOS.
LOS fell very slightly over time by on average around 0.2
to 0.4 days per year across the three sub-groups (Table 2)
and LOS was longest for individuals with a main diagno-
sis of schizophrenia (F20) or schizoaffective disorder
(F25) (Fig. 3).
Fig. 1 Variation in diagnosis by hospital provider, all years pooled
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Estimation results - overview
Table 3 shows the average partial effects (APEs) esti-
mates for the pooled model (column (1)) and then separ-
ately for the three types of SMI patient (columns (2) to
(4)). Table 4 presents the results as Incidence Rate Ratios
(IRR). In the pooled model, the majority of diagnostic
groups had a shorter LOS than schizophrenia, some as
much as 20 days shorter (F22). Diagnosis was a key pre-
dictor of LOS in the pooled model. Results were broadly
consistent across the three diagnostic groups of patients.
However, there were some differences in LOS across
diagnoses: F23, F28 and F29 had significantly shorter
LOS than schizotypal disorder (F21) of between 9 and
17 days. People with bipolar affective disorder had a sig-
nificantly longer LOS of 7 days compared to those suf-
fering from a manic episode (F30).
Estimation results – individual characteristics
Our findings suggest that most independent risk factors
do not have a differential effect for different diagnostic
sub-groups. However we do note some heterogeneity in
the effects. In terms of patient demographics and clinical
characteristics, we found an age gradient with patients
from age 65 and above with schizophrenia, and from age
55 and above for the other diagnostic subgroups and in
the pooled model, exhibiting progressively longer LOS
compared to 18–24 year-olds. This age gradient for the 65
to 74-year old age group, relative to the 18 to 24-year old
age group, was 11 days in the pooled model and ranged
from 6 days for the schizophrenia subgroup, 14 days for
schizoaffective disorder and 19 days for bipolar disorder.
Gender was not a significant predictor of LOS. Longer
LOS was associated with formal detention (16 days in the
pooled model and between 15 days for schizoaffective dis-
order and 19 days for schizophrenia) and with black ethni-
city (around 4 days), although detained patients with black
ethnicity had shorter LOS than detained white patients
(see interactions in Table 4). Having an informal carer was
associated with longer LOS in the pooled model (3 days)
although this was not significant in all models (2) to (4).
Patients with schizophrenia who had a previous psychi-
atric history had a shorter LOS of around 2.5 days, but
this was not the case in the pooled model or for any of the
other sub-groups. In the pooled model, patients from
more deprived neighbourhoods had a longer LOS (be-
tween 2 and 3 days) and the effect was larger in patients
with bipolar disorder (6 days). Having a higher number of
physical and psychiatric comorbidities was associated with
longer LOS (1 day) while shorter LOS was associated with
co-morbid substance or alcohol misuse (between 4 and
5 days), and co-morbid personality disorder (between 7
and 9 days) for all types of patient. Patients who decided
to self-discharge had shorter LOS (between 19 and
29 days). Patients whose usual place of residence was an
urban area did not have significantly different LOS com-
pared with other patients. No association was found be-
tween LOS and primary care in terms of either access or
quality variables.
Fig. 2 Histogram of length of stay, pooled across all diagnostic groups and years
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Hospital variation
Figure 4 shows histograms of the estimated hospital
fixed effects by diagnostic group. These fixed effects
could be interpreted as the predicted length of stay for a
given patient (here given by the reference category in
Table 3). The median hospital effects were 42.8 days
(Interquartile range (IQR) = 38.5 - 45.7) for schizophre-
nia (F20), 42.6 days (IQR = 38.0 - 46.0) for schizotypal
disorders (F21-F29), and 42.3 days (IQR = 38.9 - 46.5)
for bipolar and mood affective disorders (F30-F31). The
differences amongst hospital fixed effects reflect the
average effect on hospital LOS of differences across hos-
pitals in factors that we do not observe.
The correlations between the hospital effects for the
three sub-groups of patients were high (rho > 0.75) for
all pairs of diagnostic groups.
Discussion
To our knowledge, this is the first study to use large-
scale national routine data to examine the key determi-
nants of LOS for particular patient sub-groups with ser-
ious mental illness in England. Previous literature has
tended to produce inconsistent results about factors as-
sociated with LOS partly because of small sample sizes
and also due to the limitations of the methods employed
in some studies. Our main contribution to the existing
literature is in terms of our methodology which, com-
pared to other studies, provides results which are more
robust. The methodological advances include estimating
a Poisson regression model with hospital fixed effects,
rather than using a logit model to examine long-stay pa-
tients using an arbitrary cut-off point to model case-
controls, and taking account of LOS as a continuous
Fig. 3 Boxplot of length of stay by diagnosis, all years pooled
Table 2 LOS by diagnostic group and pooled over time
All (F20-F31)
(1)
Schizophrenia (F20)
(2)
Psychotic and schizoaffective disorder (F21-F29)
(3)
Manic and bipolar disorder (F30-F31)
(4)
Financial year Mean SD Mean SD Mean SD Mean SD
2006/07 44.4 40.0 48.0 43.3 41.6 38.5 41.6 35.7
2007/08 43.3 39.7 47.0 42.7 40.8 38.5 40.2 35.9
2008/09 45.0 40.1 49.0 42.9 42.1 39.1 42.2 36.7
2009/10 43.7 39.6 47.7 42.7 40.6 37.8 41.1 36.3
2010/11 42.7 38.4 46.1 40.9 40.2 37.5 40.5 35.7
Pooled 43.9 39.7 47.7 42.7 41.1 38.3 41.2 36.1
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Table 3 Factors determining hospital length of stay – regression results, Average Partial Effects (APEs)
Pooled (F20-
F31) (1)
Schizophrenia
(F20) (2)
Psychotic and
schizoaffective disorder
(F21-F29) (3)
Manic and bipolar
disorder (F30-F31) (4)
Variable APE SE APE SE APE SE APE SE
Main diagnosis
Schizophrenia (F20) (base category) (base category)
Schizotypal disorder (F21) −4.16 0.71*** (base category)
Persistent delusional disorder (F22) −19.56 1.04*** −2.12 2.86
Acute and transient psychotic disorder (F23) −11.57 4.69* −17.20 2.15***
Induced delusional disorder (F24) 0.75 0.52 −9.34 5.65
Schizoaffective disorders (F25) −11.67 2.32*** 3.78 3.18
Other nonorganic psychotic disorders (F28) −11.42 1.10*** −9.29 3.79*
Unspecified nonorganic psychosis (F29) −6.36 0.48*** −9.03 2.69***
Manic episode (F30) −3.02 2.80 (base category)
Bipolar affective disorder (F31) −12.57 1.01*** 7.42 1.27***
Patient demographics and clinical characteristics
Age 25-34 −1.63 0.61** −1.72 0.81* −0.93 1.13 −2.64 1.44
Age 35-44 −3.54 0.53*** −3.84 0.76*** −3.68 1.10*** −3.65 1.37**
Age 45-54 −2.25 0.59*** −3.22 0.98*** −2.25 1.00* −0.66 1.42
Age 55-64 1.64 0.63** −0.49 0.98 4.56 1.35*** 4.31 1.80*
Age 65-74 10.88 1.23*** 6.21 1.60*** 14.39 2.33*** 18.55 3.01***
Age 75 and over 18.64 1.57*** 11.60 2.45*** 25.57 3.84*** 27.45 3.73***
Male −0.41 0.38 −1.35 0.53* −0.62 0.62 0.72 0.77
Detained 15.98 1.17*** 19.48 1.81*** 14.72 2.26*** 16.51 1.76***
Ethnicity: mixed 2.31 0.99* 0.57 1.49 3.65 1.80* 7.74 3.45*
Ethnicity: Asian 0.69 0.64 0.68 0.82 1.92 1.42 −0.45 0.89
Ethnicity: black 4.46 0.63*** 5.28 0.93*** 3.99 1.25** 4.88 1.70**
Ethnicity: unknown or missing −0.77 0.72 0.10 1.21 −0.81 1.17 −2.31 1.87
Patient has a carer 3.16 1.14** 3.19 1.35* 1.44 1.64 5.50 2.22*
Patient was previously treated for mental health issues −1.00 0.76 −2.51 0.94** 0.15 0.94 0.41 1.22
MH benefit claimants - 2nd quintile 0.63 0.41 −0.07 0.62 1.12 0.94 1.32 0.75
MH benefit claimants - 3rd quintile 1.41 0.47** 0.59 0.67 1.24 1.00 3.14 0.97**
MH benefit claimants - 4th quintile 2.43 0.78** 1.41 0.99 1.75 1.28 5.76 1.09***
MH benefit claimants - 5th quintile 2.65 0.68*** 1.11 0.88 3.03 1.34* 6.08 1.13***
Number of comorbidities 1.17 0.33*** 1.04 0.35** 1.29 0.36*** 1.53 0.53**
Alcohol and substance misuse −4.21 0.67*** −4.96 1.05*** −2.40 1.38 −5.10 1.50***
Co-morbid personality disorder −7.81 1.30*** −9.14 2.19*** −7.18 2.91* −9.46 2.19***
Discharge
Self-discharged −19.99 1.85*** −19.24 2.48*** −20.37 3.11*** −29.17 2.76***
Died in hospital −3.30 1.64* −3.56 2.73 −0.96 4.12 −6.03 3.09
Access to care
Urban 0.41 0.61 −0.10 0.91 0.67 1.02 1.20 1.06
% residents of local community in psychiatric establishment −0.04 0.41 0.11 0.52 0.01 1.30 −0.41 0.87
Ability to access GP within 48 h −0.54 1.12 0.10 1.73 −2.74 2.68 0.10 2.79
Care plan developed in primary care −1.01 0.95 −2.18 1.57 2.92 2.16 −1.70 2.23
Jacobs et al. BMC Health Services Research  (2015) 15:439 Page 10 of 16
variable. Where many previous studies ignore hospital
effects, we examined differences in LOS between mental
health providers. Our larger sample size enabled us to
improve on previous studies by estimating separate
models for three key diagnostic sub-groups to analyse
the independent contribution of a range of potential de-
terminants of LOS on each of the broad classes of diag-
noses. Our study population was everyone admitted to
an NHS mental health hospital in England with SMI
over the period 2006 to 2010 and was considerably lar-
ger and more representative than previous studies. There
are no reliable estimates of the number of patients seek-
ing care in the private sector, but this is likely to be
small as the vast majority of mental health hospital care
in England is publicly funded. Specifically, the £143 m
market for privately funded mental health hospital care
[49] compares with £2 billion of NHS spending on
psychotic disorders [50].
Contrary to some previous studies, we found that
diagnosis was a strong predictor of LOS [40, 51]. We
found that shorter LOS was associated with co-morbid
substance or alcohol misuse, and with co-morbid per-
sonality disorder, although recorded prevalence of these
co-morbidities may be low due to poor coding. This
finding is however consistent with previous literature
and may be because when these patients’ symptoms re-
solve following inpatient detoxification, they are more
likely to leave against medical advice (self-discharge),
and may be motivated to show improvement so they can
leave to regain access to drugs or alcohol [35, 37]. In-
deed patients who self-discharged had shorter LOS. It
may also reflect the transient nature of psychotic symp-
toms in the context of substance misuse, where there is
more rapid resolution upon admission to hospital and
removal from the usual environment. While previous lit-
erature has been inconsistent with respect to the associ-
ation with age, reporting positive [30, 33, 35], and
negative findings [29, 31, 36]), in our study we found a
strong age gradient only for people aged 55 and above
(and the effect was not apparent until 65 for those with
schizophrenia). We also found, as in previous literature
[37, 38], that compulsory admission was positively asso-
ciated with LOS, increasing it by 16 days overall (19 days
for schizophrenia, 15 days for schizoaffective disorder
and 17 days for bipolar disorder). While studies have
found mixed results on the association between male
gender and LOS (positive [24, 30, 31], negative [37]),
gender was not a significant predictor of LOS in our
analyses. Previous evidence on the association between
co-morbidities and LOS has been inconsistent: while
some studies found that patients with more co-
morbidities had longer LOS [24, 29], others found that
individuals with no comorbidity had longer LOS [30].
Our study found that having a higher number of psychi-
atric and physical comorbidities was associated with lon-
ger LOS of around 1 day. Some previous studies have
reported positive associations between prior hospitalisa-
tion and LOS [35, 38] and others found a negative rela-
tionship [29]; in our analyses, only schizophrenia
patients with a psychiatric history had a shorter LOS of
around 2.5 days. This may be because these patients are
well known to services and crisis stabilisation can be
achieved more swiftly since relapse signatures will be fa-
miliar, medication regimes will be tried and tested, and
care plans are more likely to be in place.
Having a carer was associated with longer LOS overall
in the pooled model and for schizophrenia and bipolar
disorder patients, but there was no effect for schizoaffec-
tive disorder patients. It is possible that if carers experi-
ence a significant carer burden from patients with high
levels of need, LOS may be prolonged, in the interests of
protecting carers’ health and wellbeing. Just less than
7 % of patients have an unpaid carer registered in their
hospital record. The record may underestimate the ac-
tual level of both formal and informal care that this
patient population receive. If a record of having a carer
is associated with increased patient need, then this may
explain the positive association that we observe.
Table 3 Factors determining hospital length of stay – regression results, Average Partial Effects (APEs) (Continued)
Time effects
Year 2007 −1.18 0.97 −1.25 1.17 −1.27 1.45 −1.77 1.34
Year 2008 0.22 0.86 0.49 1.06 −0.44 1.19 0.43 1.37
Year 2009 −1.47 0.99 −1.34 1.33 −2.30 1.20 −1.79 1.33
Year 2010 −3.08 1.15** −3.50 1.45* −3.67 1.44* −3.22 1.78
Pseudo-R2 0.061 0.046 0.091 0.050
N 89,510 38,216 21,415 29,879
Note: Evaluated at the mean of the estimated hospital effects. Interaction effects are subsumed into main effects. Pseudo-R2 are based on model with standard
errors clustered at hospital level but no hospital fixed effects
* p < 0.05; ** p < 0.01; *** p < 0.001
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Table 4 Factors determining hospital length of stay – regression results, Incidence Rate Ratios (IRRs)
Pooled
(F20-F31) (1)
Schizophrenia
(F20) (2)
Psychotic and
schizoaffective disorder
(F21-F29) (3)
Manic and bipolar
disorder (F30-F31) (4)
Variable IRR 95 % CI IRR 95 % CI IRR 95 % CI IRR 95 % CI
Main diagnosis
Schizophrenia (F20) (base category) (base category)
Schizotypal disorder (F21) 0.91 (0.88; 0.94) (base category)
Persistent delusional disorder (F22) 0.64 (0.62; 0.66) 0.96 (0.84; 1.08)
Acute and transient psychotic disorder (F23) 0.77 (0.62; 0.95) 0.69 (0.61; 0.78)
Induced delusional disorder (F24) 1.02 (0.99; 1.04) 0.82 (0.63; 1.05)
Schizoaffective disorders (F25) 0.77 (0.69; 0.85) 1.09 (0.96; 1.23)
Other nonorganic psychotic disorders (F28) 0.77 (0.74; 0.81) 0.82 (0.68; 0.98)
Unspecified nonorganic psychosis (F29) 0.87 (0.85; 0.88) 0.82 (0.72; 0.94)
Manic episode (F30) 0.93 (0.82; 1.06) (base category)
Bipolar affective disorder (F31) 0.75 (0.72; 0.78) 1.14 (1.10; 1.18)
Patient demographics and clinical characteristics
Age 25-34 0.99 (0.93; 1.04) 1.00 (0.91; 1.10) 1.01 (0.93; 1.10) 0.96 (0.89; 1.03)
Age 35-44 0.94 (0.90; 0.99) 0.95 (0.88; 1.03) 0.94 (0.86; 1.02) 0.95 (0.88; 1.02)
Age 45-54 0.99 (0.94; 1.03) 0.98 (0.91; 1.07) 0.98 (0.91; 1.05) 1.00 (0.93; 1.08)
Age 55-64 1.10 (1.05; 1.16) 1.06 (0.97; 1.15) 1.17 (1.07; 1.27) 1.12 (1.04; 1.21)
Age 65-74 1.32 (1.25; 1.39) 1.23 (1.12; 1.34) 1.40 (1.30; 1.52) 1.37 (1.26; 1.48)
Age 75 and over 1.50 (1.41; 1.60) 1.34 (1.22; 1.48) 1.63 (1.47; 1.81) 1.56 (1.41; 1.72)
Male 1.06 (1.00; 1.12) 1.04 (0.95; 1.13) 1.05 (0.96; 1.16) 1.06 (0.99; 1.14)
Detained 1.41 (1.35; 1.47) 1.52 (1.45; 1.60) 1.35 (1.28; 1.42) 1.31 (1.25; 1.37)
Ethnicity: mixed 1.07 (1.01; 1.13) 1.05 (0.97; 1.14) 1.09 (0.99; 1.19) 1.10 (0.99; 1.23)
Ethnicity: Asian 1.03 (0.99; 1.06) 1.04 (0.99; 1.09) 1.04 (0.97; 1.12) 1.01 (0.97; 1.05)
Ethnicity: black 1.12 (1.09; 1.15) 1.15 (1.10; 1.20) 1.11 (1.05; 1.17) 1.11 (1.04; 1.17)
Ethnicity: unknown or missing 0.99 (0.95; 1.03) 1.03 (0.96; 1.09) 0.97 (0.91; 1.04) 0.95 (0.88; 1.02)
Interaction: Detained + Ethnicity: mixed 0.94 (0.84; 1.06) 0.85 (0.74; 0.98) 0.98 (0.80; 1.20) 1.14 (0.92; 1.41)
Interaction: Detained + Ethnicity: Asian 0.95 (0.89; 1.02) 0.91 (0.83; 1.00) 1.00 (0.91; 1.11) 0.93 (0.83; 1.05)
Interaction: Detained + Ethnicity: black 0.93 (0.88; 0.98) 0.90 (0.85; 0.96) 0.91 (0.84; 0.99) 0.91 (0.84; 0.98)
Interaction: Detained + Ethnicity: unknown or missing 0.99 (0.92; 1.06) 0.91 (0.82; 1.01) 1.03 (0.92; 1.16) 1.05 (0.90; 1.22)
Patient has a carer 1.07 (1.02; 1.12) 1.07 (1.01; 1.13) 1.03 (0.96; 1.10) 1.10 (1.03; 1.17)
Patient was previously treated for mental health issues 0.98 (0.94; 1.01) 0.95 (0.91; 0.99) 1.00 (0.96; 1.04) 1.01 (0.97; 1.05)
MH benefit claimants - 2nd quintile 1.01 (1.00; 1.03) 1.00 (0.97; 1.03) 1.03 (0.99; 1.07) 1.02 (1.00; 1.05)
MH benefit claimants - 3rd quintile 1.03 (1.01; 1.06) 1.01 (0.98; 1.04) 1.03 (0.99; 1.07) 1.06 (1.02; 1.09)
MH benefit claimants - 4th quintile 1.06 (1.02; 1.09) 1.03 (0.99; 1.08) 1.04 (0.99; 1.09) 1.11 (1.07; 1.14)
MH benefit claimants - 5th quintile 1.06 (1.03; 1.09) 1.03 (0.99; 1.07) 1.07 (1.01; 1.13) 1.11 (1.07; 1.15)
Number of comorbidities 1.03 (1.01; 1.04) 1.02 (1.01; 1.04) 1.03 (1.01; 1.04) 1.03 (1.01; 1.05)
Alcohol and substance misuse 0.90 (0.88; 0.93) 0.89 (0.85; 0.93) 0.95 (0.89; 1.01) 0.91 (0.86; 0.96)
Co-morbid personality disorder 0.82 (0.77; 0.88) 0.80 (0.71; 0.90) 0.84 (0.73; 0.97) 0.84 (0.77; 0.91)
Discharge
Self-discharged 0.55 (0.49; 0.62) 0.57 (0.50; 0.66) 0.56 (0.48; 0.66) 0.50 (0.44; 0.57)
Died in hospital 0.93 (0.86; 1.00) 0.92 (0.81; 1.05) 0.98 (0.82; 1.17) 0.90 (0.80; 1.01)
Access to care
Urban 1.01 (0.98; 1.04) 1.00 (0.96; 1.04) 1.01 (0.97; 1.06) 1.02 (0.99; 1.06)
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Patients with manic or bipolar disorders who were
from more deprived neighbourhoods had longer LOS
whilst this was not the case for schizophrenia patients.
Although there were similarities in the association be-
tween LOS and patient characteristics across the three
diagnostic patient groups, there were some noticeable
differences. Whilst these should be interpreted with cau-
tion, our results suggest that there may be advantages to
modelling LOS stratified by diagnostic groupings to more
accurately determine associations between case-mix which
can be used to ensure prospective payment systems reflect
accurately the resource use within sub-groups.
We found a large degree of variation in case-mix be-
tween providers. This will likely have implications for
the costs imposed on them by the risk profile of their
patient population, particularly if hospitals predomin-
antly treat older patients with complex care needs and
detained patients. We also found significant variation in
the hospital fixed effects within diagnostic groupings.
The interquartile range of the hospital fixed effects for
each diagnostic group is around 9 days suggesting a sig-
nificant spread in the distribution and large differences
between providers in the unexplained variation in LOS.
We also found a high correlation between the provider
effects across the different diagnostic groups. This sug-
gests that hospitals with unexplained high LOS for one
diagnostic group will also have high LOS for another
sub-group. These hospitals may be systematically differ-
ent in the way they manage and treat patients. Unob-
served hospital characteristics (such as the quality of
care, quality of management, unmeasured differences in
average case-mix, or differences in efficiency) therefore
appear to have similar effects on LOS for different types
of patients.
The proposed NTPS for mental health providers is
based on need and, other than assigning patients to the
super-classes of non-psychotic, psychosis and organic
mental illness, the system does not directly use diagnoses
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Fig. 4 Boxplot of hospital effects, by diagnostic group
Table 4 Factors determining hospital length of stay – regression results, Incidence Rate Ratios (IRRs) (Continued)
% residents of local community in psychiatric establishment 1.00 (0.98; 1.02) 1.00 (0.98; 1.03) 1.00 (0.95; 1.06) 0.99 (0.96; 1.02)
Ability to access GP within 48 h 0.99 (0.94; 1.04) 1.00 (0.93; 1.08) 0.94 (0.83; 1.06) 1.00 (0.91; 1.10)
Care plan developed in primary care 0.98 (0.94; 1.02) 0.95 (0.89; 1.02) 1.07 (0.98; 1.16) 0.97 (0.90; 1.05)
Time effects
Year 2007 0.97 (0.93; 1.02) 0.97 (0.92; 1.02) 0.97 (0.92; 1.03) 0.97 (0.93; 1.02)
Year 2008 1.00 (0.97; 1.04) 1.01 (0.97; 1.06) 0.99 (0.94; 1.04) 1.01 (0.96; 1.05)
Year 2009 0.97 (0.92; 1.01) 0.97 (0.92; 1.03) 0.95 (0.91; 1.00) 0.97 (0.93; 1.01)
Year 2010 0.93 (0.88; 0.98) 0.92 (0.86; 0.99) 0.92 (0.87; 0.98) 0.95 (0.89; 1.01)
Pseudo-R2 0.061 0.046 0.091 0.050
N 89,510 38,216 21,415 29,879
Note: Model includes hospital fixed effects (not shown). Age x gender interactions suppressed. Pseudo-R2 are based on model with standard errors clustered at
hospital level but no hospital fixed effects
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(ICD-10 codes) to cluster service users. The Mental
Health Clustering Tool, used to allocate service users to
the 21 clusters, explicitly states that people with the same
diagnosis can be assigned to different clusters, and that
individuals can move between clusters as their needs
change over time [52]. Our results suggest that the pay-
ment system may need to be tailored according to diag-
nostic group. A prospective payment system should be
fair (e.g. paying the same for treating patients with
similar needs), but also needs to take account of factors
beyond the control of a hospital (e.g. the characteristics
of patients such as diagnosis if this affects LOS, age, de-
tention status, local input prices). However, a balance
needs to be struck. If some factors make little economic
difference, though statistically significant, they should
not be used in the payment system as they would add
unnecessary complexity. There are also risks of unin-
tended consequences if some diagnoses or detention
status attract a higher payment, generating inappropri-
ate incentives. Finally, the argument for paying by diag-
nosis hinges on the assumption that these are well
coded. There are therefore concerns about the feasibil-
ity of implementing such a system (coding quality,
gaming, etc.).
Conclusions
This study used national administrative data linked to
publicly available datasets to produce a large sample
with a rich set of potential determinants of LOS for pa-
tients with SMI. Our data on individual patients was
more limited than in studies adopting retrospective case
note review but were comprehensive in that they cov-
ered all publicly funded hospital admissions in England.
Many of the commonly identified risk factors were
captured, although some were an imperfect match for
those identified in the literature review. Other factors
were omitted entirely due to limited data availability, in-
cluding psychiatric functioning or severity, the use of
seclusion or restraint and psychopharmacological medi-
cation. We also did not account for readmissions which
may be important in relation to LOS and payment
mechanisms, since providers with shorter LOS may
benefit from early discharge, and a subsequent new ad-
mission for which they could be paid, unless incentives
were put in place to discourage a quicker and sicker ‘re-
volving door’ phenomenon [53].
We found substantial variation between providers in un-
observed hospital characteristics (such as differences in
management culture or efficiency). Providers appear to be
systematically different in terms of their resource use and
this will likely result in some hospitals being ‘winners’ and
others ‘losers’ under a prospective payment system. Inter-
national experience suggests large variations in provider
effects with respect to costs or LOS may make a classifica-
tion system unsuitable for provider payment [13] as it may
destabilize local health economies. There is therefore a
need for a careful transition to any new payment system.
The variation in case-mix which we observed may be
the result of genuine differences in risk profiles between
providers, but may also be due to inconsistent use of
diagnostic codes between providers. There are some lim-
itations to the use of diagnostic classifications in HES
for psychiatric admissions. Diagnostic coding may be
done by staff removed from the nuances of psychiatric
diagnosis, rather than by the rigorous application of
ICD-10 criteria by clinicians. Whilst we have argued that
payment systems may need to be tailored to diagnostic
groupings, this would require the consistent and accur-
ate use of diagnostic codes across mental health pro-
viders. Whilst some mental health professionals are
reluctant to label patients, in part due to stigma, and
argue for treating the person rather than the illness [54],
diagnostic coding can be helpful to patients, by provid-
ing appropriate treatments and access to support and
services including benefits [55]. A quality indicator has
been recommended for use by commissioners and pro-
viders in drawing up contracts as part of the NTPS
which incentivises the collection of a valid ICD-10 code
[56]. Improved data quality on diagnostic coding is im-
perative for future research purposes to better under-
stand the role of diagnosis as a driver of LOS and
resource use as part of a funding system.
Challenges in future may be not just to reward hospitals
properly but also to incorporate incentives for appropriate
primary, community and social care to form part of the
care package for individuals with SMI, moving towards
personalised funding. Future research should therefore
focus on examining cost drivers across the full range of
services that SMI patients utilise and across the full pa-
tient care pathway. This will support the design and reim-
bursement of more effective and efficient care pathways.
Inpatient LOS for SMI patients will remain an expensive
but important component of that pathway and therefore
understanding the key determinants of LOS is vital as
mental health service commissioners and providers grap-
ple with the challenges of continued cost pressures.
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